BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29685804)

  • 1. Investigation of the kinetics and mechanism of low endotoxin recovery in a matrix for biopharmaceutical drug products.
    Reich J; Tamura H; Nagaoka I; Motschmann H
    Biologicals; 2018 May; 53():1-9. PubMed ID: 29685804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Masking of endotoxin in surfactant samples: Effects on Limulus-based detection systems.
    Reich J; Lang P; Grallert H; Motschmann H
    Biologicals; 2016 Sep; 44(5):417-22. PubMed ID: 27464990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sample Treatments That Solve Low Endotoxin Recovery Issues.
    Tsuchiya M
    PDA J Pharm Sci Technol; 2019; 73(5):433-442. PubMed ID: 30902837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of different sample treatment methods on Low Endotoxin Recovery Phenomenon.
    Bu R; Deng X; Cao Y; Jin J; Mai B; Meng K; Liu X; Chi JC; Zhang Y; Qiu F
    J Microbiol Methods; 2021 Jul; 186():106241. PubMed ID: 33992679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial Endotoxin Testing-Fast Endotoxin Masking Kinetics in the Presence of Lauryldimethylamine Oxide.
    Bech Ørving R; Carpenter B; Roth S; Reich J; Kallipolitis B; Sonne-Hansen J
    Microorganisms; 2020 Nov; 8(11):. PubMed ID: 33158205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biophysical Analysis of Lipopolysaccharide Formulations for an Understanding of the Low Endotoxin Recovery (LER) Phenomenon.
    Correa W; Brandenburg K; Zähringer U; Ravuri K; Khan T; von Wintzingerode F
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29258200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supramolecular assembly of micellar aggregates is the basis of low endotoxin recovery (LER) in a drug formulation that can be resolved by a whole blood assay.
    Schromm AB; Correa W; Gisch N; Steiniger F; Richter W; Martinez-de-Tejada G; Brandenburg K; von Wintzingerode F
    Biomed Pharmacother; 2024 Apr; 173():116286. PubMed ID: 38401515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Affecting Reduction of Reference Endotoxin Standard Activity Caused by Chelating Agent/Detergent Matrices: Kinetic Analysis of Low Endotoxin Recovery.
    Tsuchiya M
    PDA J Pharm Sci Technol; 2017; 71(6):478-487. PubMed ID: 28928294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endotoxin recovery using limulus amebocyte lysate (LAL) assay.
    Bolden JS; Warburton RE; Phelan R; Murphy M; Smith KR; De Felippis MR; Chen D
    Biologicals; 2016 Sep; 44(5):434-40. PubMed ID: 27470947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low endotoxin recovery and its impact on endotoxin detection.
    Cao Y; Zhang Y; Qiu F
    Biopolymers; 2021 Nov; 112(11):e23470. PubMed ID: 34407207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteinase K digestion of proteins improves detection of bacterial endotoxins by the Limulus amebocyte lysate assay: application for endotoxin removal from cationic proteins.
    Petsch D; Deckwer WD; Anspach FB
    Anal Biochem; 1998 May; 259(1):42-7. PubMed ID: 9606141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low Endotoxin Recovery-Masking of Naturally Occurring Endotoxin.
    Reich J; Weyer FA; Tamura H; Nagaoka I; Motschmann H
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of Recombinant Factor C Reagent for the Detection of Bacterial Endotoxins in Pharmaceutical Products.
    Bolden J; Smith K
    PDA J Pharm Sci Technol; 2017; 71(5):405-412. PubMed ID: 28733334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of Turbidimetric Limulus Amebocyte Lysate Assay for the Recovery of Endotoxin Interacted with Commonly Used Antimicrobial Agents of Endodontic Therapy.
    Marinho AC; Polay AR; Gomes BP
    J Endod; 2015 Oct; 41(10):1653-9. PubMed ID: 26254546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intralaboratory validation of kinetic chromogenic Limulus amebocyte lysate assay for bacterial endotoxin determination in anti-bothropic serum.
    Fingola FF; Albertino SR; Abrantes Sde M; Zamith HP
    J Pharm Biomed Anal; 2013 Nov; 85():93-8. PubMed ID: 23912057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence against a bacterial endotoxin masking effect in biologic drug products by limulus amebocyte lysate detection.
    Bolden JS; Claerbout ME; Miner MK; Murphy MA; Smith KR; Warburton RE
    PDA J Pharm Sci Technol; 2014; 68(5):472-7. PubMed ID: 25336418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of a bacterial endotoxin test for parenteral drugs].
    Ogawa Y
    Eisei Shikenjo Hokoku; 1994; (112):209-11. PubMed ID: 8854936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saline and buffers minimize the action of interfering factors in the bacterial endotoxins test.
    Fujita Y; Tokunaga T; Kataoka H
    Anal Biochem; 2011 Feb; 409(1):46-53. PubMed ID: 20951111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A modified Limulus amebocyte lysate test with increased sensitivity for detection of bacterial endotoxin.
    Roth RI; Levin J; Behr S
    J Lab Clin Med; 1989 Sep; 114(3):306-11. PubMed ID: 2671216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of a chromogenic Limulus amebocyte lysate (LAL) assay for automated endotoxin detection.
    Bussey DM; Tsuji K
    J Parenter Sci Technol; 1984; 38(6):228-33. PubMed ID: 6527205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.